Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 5 | 2023 | 420 | 1.460 |
Why?
|
| Wounds and Injuries | 3 | 2021 | 250 | 0.910 |
Why?
|
| Abdominal Cavity | 1 | 2023 | 7 | 0.810 |
Why?
|
| Abdominal Wall | 2 | 2022 | 24 | 0.770 |
Why?
|
| Critical Care | 3 | 2023 | 400 | 0.770 |
Why?
|
| Practice Management | 1 | 2022 | 3 | 0.740 |
Why?
|
| Abdominal Wound Closure Techniques | 1 | 2022 | 3 | 0.740 |
Why?
|
| Intestinal Fistula | 1 | 2022 | 13 | 0.730 |
Why?
|
| Critical Illness | 3 | 2023 | 328 | 0.730 |
Why?
|
| Abdominal Injuries | 1 | 2022 | 31 | 0.720 |
Why?
|
| Medication Reconciliation | 1 | 2021 | 14 | 0.690 |
Why?
|
| Practice Guidelines as Topic | 3 | 2023 | 734 | 0.540 |
Why?
|
| Abdomen | 2 | 2023 | 94 | 0.370 |
Why?
|
| Cost Savings | 1 | 2012 | 57 | 0.360 |
Why?
|
| Hernia, Ventral | 2 | 2023 | 27 | 0.350 |
Why?
|
| Injury Severity Score | 7 | 2022 | 117 | 0.350 |
Why?
|
| Rib Fractures | 2 | 2022 | 22 | 0.350 |
Why?
|
| Intervertebral Disc | 4 | 2014 | 21 | 0.340 |
Why?
|
| Wounds, Nonpenetrating | 4 | 2021 | 116 | 0.340 |
Why?
|
| Trauma Centers | 3 | 2012 | 130 | 0.340 |
Why?
|
| Survivors | 2 | 2023 | 186 | 0.340 |
Why?
|
| Intussusception | 1 | 2011 | 16 | 0.330 |
Why?
|
| Colonic Diseases | 1 | 2011 | 34 | 0.330 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2021 | 1653 | 0.330 |
Why?
|
| Disaster Planning | 2 | 2008 | 55 | 0.280 |
Why?
|
| Adult | 13 | 2023 | 17271 | 0.280 |
Why?
|
| Brain Injuries | 2 | 2015 | 141 | 0.280 |
Why?
|
| Mass Casualty Incidents | 1 | 2008 | 31 | 0.270 |
Why?
|
| Hemorrhage | 2 | 2020 | 278 | 0.270 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 286 | 0.270 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 364 | 0.260 |
Why?
|
| Surgical Mesh | 3 | 2023 | 60 | 0.260 |
Why?
|
| Cortical Spreading Depression | 2 | 2017 | 9 | 0.250 |
Why?
|
| Retrospective Studies | 10 | 2023 | 6823 | 0.250 |
Why?
|
| Hypercalcemia | 1 | 2006 | 12 | 0.240 |
Why?
|
| Parathyroid Hormone | 1 | 2006 | 44 | 0.240 |
Why?
|
| Humans | 25 | 2023 | 64818 | 0.240 |
Why?
|
| Prospective Studies | 5 | 2023 | 3300 | 0.230 |
Why?
|
| Smoke Inhalation Injury | 1 | 2005 | 3 | 0.230 |
Why?
|
| Fires | 1 | 2005 | 17 | 0.220 |
Why?
|
| Hedgehog Proteins | 4 | 2014 | 116 | 0.220 |
Why?
|
| Burns | 1 | 2005 | 45 | 0.220 |
Why?
|
| Male | 18 | 2023 | 30880 | 0.210 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 176 | 0.210 |
Why?
|
| Vascular System Injuries | 2 | 2021 | 22 | 0.210 |
Why?
|
| Wounds, Penetrating | 2 | 2021 | 32 | 0.210 |
Why?
|
| Middle Aged | 12 | 2023 | 18163 | 0.210 |
Why?
|
| Herniorrhaphy | 2 | 2023 | 71 | 0.200 |
Why?
|
| Multiple Trauma | 1 | 2003 | 29 | 0.200 |
Why?
|
| Lumbar Vertebrae | 3 | 2011 | 174 | 0.200 |
Why?
|
| Motor Vehicles | 1 | 2023 | 32 | 0.200 |
Why?
|
| Hypotension | 1 | 2003 | 50 | 0.200 |
Why?
|
| Patient Readmission | 3 | 2023 | 446 | 0.200 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 309 | 0.200 |
Why?
|
| Sleep Aids, Pharmaceutical | 1 | 2023 | 1 | 0.190 |
Why?
|
| Incisional Hernia | 1 | 2023 | 15 | 0.190 |
Why?
|
| Sleep Deprivation | 1 | 2023 | 17 | 0.190 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 45 | 0.190 |
Why?
|
| Wound Infection | 1 | 2002 | 29 | 0.190 |
Why?
|
| Fasciotomy | 1 | 2022 | 11 | 0.190 |
Why?
|
| Accidents, Traffic | 1 | 2023 | 140 | 0.180 |
Why?
|
| Delirium | 1 | 2023 | 55 | 0.180 |
Why?
|
| Laparotomy | 1 | 2022 | 54 | 0.180 |
Why?
|
| Length of Stay | 5 | 2023 | 823 | 0.180 |
Why?
|
| ABO Blood-Group System | 1 | 2021 | 3 | 0.180 |
Why?
|
| Biological Products | 1 | 2023 | 92 | 0.170 |
Why?
|
| Staphylococcus aureus | 1 | 2002 | 180 | 0.170 |
Why?
|
| Disease Progression | 2 | 2023 | 1214 | 0.170 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2021 | 10 | 0.170 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2021 | 58 | 0.170 |
Why?
|
| Aged | 8 | 2023 | 14879 | 0.170 |
Why?
|
| Pharmacists | 1 | 2023 | 130 | 0.170 |
Why?
|
| Thoracic Injuries | 1 | 2021 | 46 | 0.170 |
Why?
|
| Thrombelastography | 1 | 2020 | 4 | 0.170 |
Why?
|
| Sternotomy | 1 | 2020 | 12 | 0.170 |
Why?
|
| Heart Injuries | 1 | 2020 | 19 | 0.170 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 105 | 0.170 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 23 | 0.170 |
Why?
|
| Thoracotomy | 1 | 2020 | 47 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2020 | 36 | 0.160 |
Why?
|
| Female | 13 | 2023 | 33854 | 0.160 |
Why?
|
| International Classification of Diseases | 1 | 2020 | 136 | 0.160 |
Why?
|
| Sleep | 1 | 2023 | 239 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2020 | 164 | 0.150 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1275 | 0.150 |
Why?
|
| Skin | 1 | 2002 | 415 | 0.150 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 125 | 0.150 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2019 | 4 | 0.150 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 152 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2021 | 581 | 0.150 |
Why?
|
| Growth Plate | 4 | 2012 | 14 | 0.150 |
Why?
|
| Cell Differentiation | 4 | 2012 | 1380 | 0.140 |
Why?
|
| Recurrence | 4 | 2023 | 654 | 0.140 |
Why?
|
| Signal Transduction | 4 | 2014 | 3137 | 0.130 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 267 | 0.130 |
Why?
|
| Cerebral Infarction | 1 | 2017 | 84 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 348 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 315 | 0.120 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 109 | 0.120 |
Why?
|
| Cerebrovascular Trauma | 1 | 2015 | 2 | 0.120 |
Why?
|
| Skull Fractures | 1 | 2015 | 20 | 0.110 |
Why?
|
| Spinal Fractures | 1 | 2015 | 41 | 0.110 |
Why?
|
| Triage | 2 | 2008 | 134 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2023 | 5773 | 0.110 |
Why?
|
| Rhode Island | 2 | 2005 | 109 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 86 | 0.100 |
Why?
|
| Aging | 2 | 2009 | 762 | 0.100 |
Why?
|
| Radiation Effects | 1 | 2012 | 3 | 0.090 |
Why?
|
| Glasgow Coma Scale | 2 | 2021 | 48 | 0.090 |
Why?
|
| Radiometry | 1 | 2012 | 39 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2021 | 873 | 0.090 |
Why?
|
| Quality Control | 1 | 2012 | 78 | 0.090 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2012 | 51 | 0.090 |
Why?
|
| Animals | 12 | 2020 | 21259 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2012 | 139 | 0.090 |
Why?
|
| Young Adult | 3 | 2021 | 4782 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 456 | 0.080 |
Why?
|
| Registries | 2 | 2005 | 902 | 0.080 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 294 | 0.070 |
Why?
|
| United States | 3 | 2021 | 8058 | 0.070 |
Why?
|
| Incidence | 2 | 2021 | 1411 | 0.070 |
Why?
|
| Mice | 8 | 2014 | 11070 | 0.070 |
Why?
|
| Macrophages | 2 | 2005 | 1035 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2021 | 881 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2015 | 524 | 0.070 |
Why?
|
| Risk Factors | 3 | 2023 | 5401 | 0.070 |
Why?
|
| Swine | 2 | 2019 | 394 | 0.060 |
Why?
|
| Hormones, Ectopic | 1 | 2006 | 3 | 0.060 |
Why?
|
| Hyperparathyroidism | 1 | 2006 | 8 | 0.060 |
Why?
|
| Parathyroid Glands | 1 | 2006 | 9 | 0.060 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2006 | 10 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2006 | 43 | 0.060 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2006 | 34 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2012 | 2607 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 895 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 122 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2012 | 2091 | 0.060 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 2005 | 8 | 0.060 |
Why?
|
| Regional Medical Programs | 1 | 2005 | 8 | 0.060 |
Why?
|
| Arginase | 1 | 2005 | 7 | 0.060 |
Why?
|
| Wound Healing | 2 | 2005 | 193 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2005 | 22 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2005 | 74 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2005 | 194 | 0.050 |
Why?
|
| Hernia, Inguinal | 1 | 2005 | 41 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 129 | 0.050 |
Why?
|
| Age Distribution | 1 | 2005 | 260 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2005 | 50 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2014 | 2146 | 0.050 |
Why?
|
| Causality | 1 | 2003 | 59 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2005 | 201 | 0.050 |
Why?
|
| Health Services Research | 1 | 2005 | 265 | 0.050 |
Why?
|
| Systole | 1 | 2003 | 109 | 0.050 |
Why?
|
| Resuscitation | 1 | 2003 | 67 | 0.050 |
Why?
|
| Surgical Sponges | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2003 | 100 | 0.050 |
Why?
|
| Bias | 1 | 2023 | 115 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2005 | 488 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 60 | 0.050 |
Why?
|
| Professional Role | 1 | 2023 | 45 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2003 | 210 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2023 | 134 | 0.040 |
Why?
|
| Neutrophils | 1 | 2005 | 386 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2021 | 10 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2002 | 518 | 0.040 |
Why?
|
| Blood Coagulation Tests | 1 | 2020 | 6 | 0.040 |
Why?
|
| Gastroscopy | 1 | 2020 | 23 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2020 | 30 | 0.040 |
Why?
|
| Propensity Score | 1 | 2021 | 189 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 372 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2002 | 574 | 0.040 |
Why?
|
| Enteral Nutrition | 1 | 2020 | 53 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2005 | 490 | 0.040 |
Why?
|
| Cattle | 1 | 2020 | 318 | 0.040 |
Why?
|
| Wnt Proteins | 2 | 2011 | 104 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2278 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 141 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 843 | 0.040 |
Why?
|
| Bandages | 1 | 2019 | 16 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2009 | 185 | 0.040 |
Why?
|
| Hemostatics | 1 | 2019 | 27 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1103 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 396 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 1267 | 0.030 |
Why?
|
| Electrocorticography | 1 | 2017 | 3 | 0.030 |
Why?
|
| Cell Division | 2 | 2009 | 448 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2020 | 1314 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2019 | 158 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2012 | 1034 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2005 | 2754 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 796 | 0.030 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2015 | 6 | 0.030 |
Why?
|
| Microelectrodes | 1 | 2015 | 14 | 0.030 |
Why?
|
| Skull | 1 | 2015 | 52 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2015 | 34 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2015 | 34 | 0.030 |
Why?
|
| Electrophysiology | 1 | 2015 | 89 | 0.030 |
Why?
|
| Phenotype | 2 | 2012 | 1231 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 2482 | 0.030 |
Why?
|
| Biomarkers | 2 | 2012 | 1472 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2015 | 103 | 0.030 |
Why?
|
| Liver | 1 | 2019 | 868 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2015 | 87 | 0.030 |
Why?
|
| Adolescent | 1 | 2005 | 6280 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 119 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 602 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 622 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 211 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2012 | 10 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2012 | 29 | 0.020 |
Why?
|
| Integrases | 1 | 2012 | 41 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2005 | 620 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 238 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2011 | 5 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2011 | 29 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2011 | 23 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 46 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 1989 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2011 | 38 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2011 | 45 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 310 | 0.020 |
Why?
|
| Cell Line | 2 | 2005 | 2019 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 240 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2011 | 224 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 709 | 0.020 |
Why?
|
| Notochord | 1 | 2009 | 9 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 47 | 0.020 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2009 | 9 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2009 | 64 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2009 | 77 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 181 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 324 | 0.020 |
Why?
|
| Histones | 1 | 2011 | 494 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 1192 | 0.020 |
Why?
|
| Biological Dressings | 1 | 2005 | 4 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2005 | 2 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2005 | 32 | 0.010 |
Why?
|
| Polyvinyl Alcohol | 1 | 2005 | 11 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2005 | 9 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2005 | 84 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 52 | 0.010 |
Why?
|
| Superoxides | 1 | 2005 | 73 | 0.010 |
Why?
|
| Peritoneum | 1 | 2005 | 31 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2005 | 104 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 144 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2005 | 202 | 0.010 |
Why?
|
| Neutropenia | 1 | 2005 | 68 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2005 | 147 | 0.010 |
Why?
|
| Solubility | 1 | 2005 | 191 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2005 | 144 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2005 | 179 | 0.010 |
Why?
|
| Hypoxia | 1 | 2005 | 119 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 3750 | 0.010 |
Why?
|
| Apoptosis | 1 | 2009 | 1095 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 323 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 320 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 478 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 602 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 1286 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 630 | 0.010 |
Why?
|
| Cytokines | 1 | 2005 | 951 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 875 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 2183 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2005 | 706 | 0.010 |
Why?
|
| Inflammation | 1 | 2005 | 1186 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 3467 | 0.010 |
Why?
|